Manulife (Manufacturers Life Insurance)
HUMA icon

Manulife (Manufacturers Life Insurance)’s Humacyte HUMA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-46,547
Closed -$28.2K – 2923
2026
Q1 		$28.2K Sell
46,547
-2,281
-5% -$2.37K ﹤0.01% 2782
2025
Q4 		$46.9K Buy
48,828
+6,256
+15% +$8.86K ﹤0.01% 2827
2025
Q3 		$74.1K Sell
42,572
-3,388
-7% -$6.64K ﹤0.01% 2830
2025
Q2 		$96.1K Buy
45,960
+13,407
+41% +$25.8K ﹤0.01% 2766
2025
Q1 		$55.5K Sell
32,553
-11,379
-26% -$42.7K ﹤0.01% 2815
2024
Q4 		$222K Sell
43,932
-1,643
-4% -$8.13K ﹤0.01% 2578
2024
Q3 		$248K Buy
45,575
+10,656
+31% +$70.3K ﹤0.01% 2569
2024
Q2 		$168K Buy
34,919
+8,557
+32% +$44.5K ﹤0.01% 2668
2024
Q1 		$82K Sell
26,362
-2,159
-8% -$7.26K ﹤0.01% 2824
2023
Q4 		$81K Hold
28,521
– – ﹤0.01% 2866
2023
Q3 		$83.6K Hold
28,521
– – ﹤0.01% 2861
2023
Q2 		$81.6K Buy
28,521
+13,303
+87% +$48K ﹤0.01% 2911
2023
Q1 		$47K Hold
15,218
– – ﹤0.01% 2869
2022
Q4 		$32.1K Buy
+15,218
New +$46.2K ﹤0.01% 2937

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s HUMA Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) sold out of Humacyte (HUMA) in Q2 2026, closing a stake of 46,547 shares — an estimated $28.2K sold.

Manulife (Manufacturers Life Insurance) first reported a position in HUMA in Q4 2022 and held it in 14 quarters. The position peaked at $248K in Q3 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) reported no remaining Humacyte position as of Q2 2026 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 46,547 Humacyte shares in Q2 2026, an estimated $28.2K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Humacyte in Q4 2022 and held it in 14 quarters.
  • Manulife (Manufacturers Life Insurance)'s Humacyte position peaked at $248K in Q3 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.